Ciencias de la Salud
Field of knowledge
Organización Nacional De Trasplantes
Madrid, EspañaPublications in collaboration with researchers from Organización Nacional De Trasplantes (18)
2024
-
GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study
eClinicalMedicine, Vol. 74
-
Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch
Transplantation, Vol. 108, Núm. 3, pp. 787-801
2022
-
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss
American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181
-
Live donor kidney transplantation. Situation analysis and roadmap
Nefrologia, Vol. 42, Núm. 1, pp. 85-93
2021
-
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155
2020
-
Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 8, pp. 379-389
-
Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus
Transplantation Reviews, Vol. 34, Núm. 2
2019
-
Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation
Journal of Hepatology, Vol. 70, Núm. 4, pp. 658-665
-
Reply to: “Normothermic regional perfusion – What is the benefit?”
Journal of Hepatology
-
The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation
Journal of Hepatology
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2016
-
Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))
Journal of Hepatology
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
2015
-
A Spanish version for the new ERA-EDTA coding system for primary renal disease
Nefrologia, Vol. 35, Núm. 4, pp. 353-357
-
Activity and results of liver transplantation in Spain during 1984-2012. Analysis of the Spanish Liver Transplant Registry
Medicina Clinica, Vol. 144, Núm. 8, pp. 337-347
-
Clinical evolution of chronic renal patients with HIV infection in replacement therapy
Nefrologia, Vol. 35, Núm. 5, pp. 457-464
-
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
Journal of Hepatology, Vol. 62, Núm. 1, pp. 92-100